GlobeNewswire

Nordea Bank Abp: First Quarter Results 2019

Share

COPENHAGEN, Denmark, April 30, 2019 (GLOBE NEWSWIRE) --

Ticker: XHFT

First Quarter Results 2019

Nordea Bank Abp - Inside information - Interim report (Q1 and Q3)

CEO Casper von Koskull's comments on the results:

"Through the actions we have taken in recent quarters there are now some encouraging signs of improved business momentum, although lending margins are under continued pressure and market making activities remain challenging.

Compared to the previous quarter, reported revenues were largely unchanged while revenues excluding items affecting comparability increased by 4%. Reported costs increased by 5%, while adjusted for resolution fees in this quarter and excluding items affecting comparability were down 7%.

Our priorities are very clear - to increase business momentum and at the same time reduce the structural cost base; we are executing on both.

This quarter, there has been an intense debate about various anti-money laundering ("AML") issues. It is a very complex and broad issue in society and we take our responsibility very seriously. We have previously stated that we expect to be fined in Denmark for our past weak AML processes and procedures, and we are consequently making a provision of EUR 95m for AML-related matters. Having invested more than EUR 700m in strengthening our risk and compliance activities in 2016-2018, we are confident that our compliance platform is of sounder quality, making us a safe and trusted partner".

First quarter 2019 vs. First quarter 2018 (First quarter 2019 vs. Fourth quarter 2018)

  • Net interest income EUR 1,056m, -5%; -4% in local currencies (-8%, -7% in local currencies)
  • Total operating income EUR 2,115m, -11%; -10% in local currencies (0%, 0% in local currencies)
  • Total operating income, excl. items affecting comparability1 EUR 2,115m, -6%; -4% in local currencies (4%, 4% in local currencies)
  • Total operating expenses EUR 1,452m, 6%; 7% in local currencies2 (5%, 5% in local currencies)
  • Total operating expenses, excl. items affecting comparability EUR 1,357m, -1%; 0% in local currencies (9%, 10% in local currencies)
  • Profit before loan losses EUR 663m, -34%; -33% in local currencies (-10%, -9% in local currencies)
  • Net loan losses EUR 42m, 5%; 5% in local currencies (40%, 40% in local currencies)
  • Operating profit EUR 621m, -36%; -35% in local currencies (-12%, -11% in local currencies)
  • Common Equity Tier 1 capital ratio 14.6% vs.19.8% (14.6% vs. 15.5%) 
  • Cost/income ratio 69% vs. 58% (69% vs. 65%)
  • Cost/income ratio, excl. items affecting comparability2 64% vs. 61% (64% vs. 61%)
  • Loan loss ratio of 7 bps vs. 7 bps (7 bps vs. 5 bps)
  • Return on equity 5.5% vs 9.0% (5.5% vs. 6.3%)
  • Return on equity with perodised resolution fees 7.4% vs 10.5% (7.4% vs. 5.8%)
  • Return on equity, excl. items affecting comparability1,2 6.7% vs 7.7% (6.7% vs. 7.1%)
  • Diluted EPS EUR 0.10 vs. EUR 0.18 (EUR 0.10 vs. EUR 0.13)

Exchange rates used for Q1 2019 for income statement items are for DKK 7.4636, NOK 9.7459 and SEK 10.4181.
Excl. Items affecting comparability in Q4 2018:  EUR 50m gain from revaluation of Euroclear, EUR 38m after tax, and EUR 36m gain related to sale of Nordea Ejendomme. Q1 2018: EUR 135m gain from valuation model update in Denmark, EUR 105m after tax.
2 Excl. Items affecting comparability in Q1 2019: EUR 95m non-deductible expense related to provision for AML-related matters In Q4 2018: EUR 141m loss from impairment of goodwill in Russia.

Income statement  
                 
  Q1 Q4   Local Q1   Local  
  2019 2018 Chg % curr. % 2018 Chg % curr. %  
EURm                
Net interest income 1,056 1,142 -8 -7 1,116 -5 -4  
Net fee and commission income 737 720 2 3 770 -4 -3  
Net result from items at fair value 264 182 45 41 441 -40 -40  
Profit from associated undertakings and joint                
ventures accounted for under the equity method 14 15     28      
Other operating income 44 60 -27 -25 23 91 96  
Total operating income 2,115 2,119 0 0 2,378 -11 -10  
                 
Staff costs -718 -744 -3 -3 -798 -10 -9  
Other expenses -594 -390 52 53 -503 18 20  
Depreciation, amortisation and impairment                
charges of tangible and intangible assets -140 -250 -44 -44 -71 97 99  
Total operating expenses -1,452 -1,384 5 5 -1,372 6 7  
                 
Profit before loan losses 663 735 -10 -9 1,006 -34 -33  
                 
Net loan losses -42 -30 40 40 -40 5 5  
Operating profit 621 705 -12 -11 966 -36 -35  
                 
Income tax expense -178 -200 -11 -11 -229 -22 -21  
Net profit for the period 443 505 -12 -11 737 -40 -39  
                 
Business volumes, key items 1  
                 
  31 Mar 31 Dec   Local 31 Mar   Local  
  2019 2018 Chg % curr. % 2018 Chg % curr. %  
EURbn                
Loans to the public 325.6 308.3 5.6 5.5 310.9 4.7 5.0  
Loans to the public, excl. repos 300.6 291.6 3.1 3.0 287.5 4.6 4.9  
Deposits and borrowings from the public 176.3 165.0 6.9 6.9 174.0 1.3 1.3  
Deposits from the public, excl. repos 166.6 160.2 4.0 4.0 161.0 3.5 3.4  
Total assets 590.2 551.4 7.0   580.2 1.7    
Assets under management 300.2 282.6 6.2   320.1 -6.2    
Equity 30.5 32.9 -7.3   31.0 -1.6    
                 
Ratios and key figures 2  
                 
  Q1 Q4     Q1      
  2019 2018 Chg %   2018 Chg %    
Diluted earnings per share, EUR 0.10 0.13 -23   0.18 -44    
EPS, rolling 12 months up to period end, EUR 0.68 0.76 -11   0.72 -6    
Share price1, EUR 6.80 7.30 -7   8.66 -21    
Total shareholders' return, % 3.3 -17.5     -3.9      
Equity per share1, EUR 7.55 8.15 -7   7.63 -1    
Potential shares outstanding1, million 4050 4,050 0   4,050 0    
Weighted average number of diluted shares, mn 4033 4,037 0   4,038 0    
Return on equity, % 5.5 6.3     9.0      
Return on tangible equity, % 6.4 7.2     10.2      
Return on Risk Exposure Amount, % 1.1 1.3     2.4      
Return on Equity with periodised resolution fees, % 7.0 5.9     10.2      
Cost/income ratio, % 69 65     58      
Cost/income ratio with periodised resolution fees, % 61 67     52      
Loan loss ratio, basis points4 7 5 40   7 0    
Common Equity Tier 1 capital ratio1,4,5, % 14.6 15.5     19.8      
Tier 1 capital ratio1,4,5, % 17.1 17.3     22.2      
Total capital ratio1,4,5, % 19.5 19.9     25.2      
Tier 1 capital1,4, EURbn 27.8 27.0 3   27.3 2    
Risk exposure amount4, EURbn 163 156 5   123 33    
Number of employees (FTEs)1 29,284 28,990 1   30,082 -3    
Economic capital1, EURbn 28.2 26.6 6   26.2 8    
End of period.  
2 For more detailed information regarding ratios and key figures defined as Alternative performance measures, see www.nordea.com/en/investor-relations/.  
3 Including Loans to the public reported in Assets held for sale in Q1 2018.  
Including the result for the period.  
Changes to the applicable capital requirements regime (for more details, please see chapter Other information).  

Outlook
Key drivers of the outlook
Throughout Nordea, we are intensifying our efforts to increase business momentum and each business area has identified a number of initiatives to drive client value and revenue growth. Examples include investments in Private Banking in Norway and Sweden, the acquisition of Gjensidige Bank, new distribution channels within Asset Management and Wholesale Banking and actions to regain momentum on mortgages, where we are already starting to see results.

The key drivers behind the structural cost efficiency are increased usage of automation and robotics, the ongoing ramp-up in Poland and Estonia and outsourcing of Group Technology mainframe to IBM. We are also simplifying by harmonising products and services and leveraging scale by further consolidating common units, for instance global operations and services.

Cost
For 2021, we expect the cost base in constant currencies to be approximately 3% below the 2018 cost base excluding items affecting comparability in 20181 and cash costs are expected to be down by up to 10% in constant currencies over the same period.

Costs for 2019 are expected to be lower in constant currencies compared to 2018 excluding items affecting comparability in 2018 and 20192 and the total cash cost is expected to be lower in constant currencies over the same period.

1 Goodwill write-down of EUR 141m in Q4 2018
2 Adjusted for the goodwill write-down of EUR 141m in 2018, transaction costs of EUR 90m in 2019, higher resolution fee in 2019 and provision of EUR 95m in Q1 2019

Credit quality
Our expectation for the coming quarters is that net losses will remain low and around the average level for 2018.

Capital policy
Given the implementation of transitional arrangements agreed with the ECB following Nordea's transfer to the Banking Union and with the aim to maintain the same nominal management buffer, the management buffer has been adjusted from a range of 50-150 bps to 40-120 bps. This is mainly a technical adjustment and hence the management buffer remains largely unchanged in nominal EUR amounts. The current level of the management buffer is approximately EUR 2.2bn (130 bps). Nordea aims to achieve a yearly increase in the dividend per share, while maintaining a strong capital position in line with the capital policy.

The entire report can be found on the below link on our website.
Nordea Group Q1 2019 Report
http://www.rns-pdf.londonstockexchange.com/rns/5223X_1-2019-4-30.pdf

For further information:

Casper von Koskull, President and Group CEO, +358 503 821 391 Christopher Rees, Group CFO, +45 5547 2377
Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15 Sara Helweg-Larsen, Head of Group Communications, +45 2214 0000


The information provided in this stock exchange release was submitted for publication through the agency of the contact persons set out above at 07:30 EET (06:30 CET) on 30 April 2019.

We build strong and close relationships through our engagement with customers and society. Whenever people strive to reach their goals and realise their dreams, we are there to provide relevant financial solutions. We are the largest bank in the Nordic region and among the ten largest financial groups in Europe in terms of total market capitalisation with around 11 million customers. The Nordea share is listed on the Nasdaq Helsinki, Nasdaq Copenhagen and Nasdaq Stockholm exchanges. Read more about us on nordea.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

CHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancer29.5.2020 12:03:00 CESTPress release

·Rozlytrek has shown durable responses across multiple tumour types, including cancer that has spread to the brain, and could become Roche’s first tumour-agnostic therapy in Europe Basel, 29 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion under conditional marketing authorisation for Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and who have not received a prior NTRK inhibitor, who have no satisfactory treatment options. The CHMP has also recommended Rozlytrek for the treatment of adults with ROS1-positive, advanced non-small cell lung cancer (NSCLC) not previously treated with RO

RESULT OF RIKSBANK REVERSED AUCTION SEK BONDS MAY 29, 202029.5.2020 10:09:32 CESTPress release

Auction date2020-05-29Loan1061Coupon0.75 %ISIN-codeSE0011281922Maturity2029-11-12Tendered volume, SEK mln1,000 +/- 250Volume offered, SEK mln3,825Volume bought, SEK mln1,000Number of bids17Number of accepted bids2Average yield-0.040 %Lowest accepted yield-0.040 %Highest yield-0.039 %% accepted at lowest yield 90.00 Auction date 2020-05-29 Loan 1062 Coupon 0.125 % ISIN-code SE0013935319 Maturity 2031-05-12 Tendered volume, SEK mln 1,000 +/- 250 Volume offered, SEK mln 4,150 Volume bought, SEK mln 1,000 Number of bids 15 Number of accepted bids 4 Average yield 0.093 % Lowest accepted yield 0.089 % Highest yield 0.096 % % accepted at lowest yield 100.00

Pawel Wyszynski new Head of Investor Relations at SEB29.5.2020 09:00:00 CESTPress release

Press release Stockholm 29 May 2020 Pawel Wyszynski has been appointed new Head of Investor Relations at SEB and will assume his position on 7 September 2020. Prior to joining SEB, Pawel Wyszynski has held the position as Director of Shareholder Relations at EQT and he has a solid background as Equity Analyst at Nordea, Danske Bank and Crédit Agricole Cheuvreux. The present Head of Investor Relations, Christoffer Geijer, will join the management team of SEB Investment Management to lead the effort to enhance the distribution of SEB IM’s product offering. For further information, please contact Frank Hojem, Head of Corporate Communication +46(0)8 763 99 47 frank.hojem@seb.se SEB is a leading Nordic financial services group with a strong belief that entrepreneurial minds and innovative companies are key in creating a better world. SEB takes a long-term perspective and supports its customers in good times and bad. In Sweden and the Baltic countries, SEB offers financial advice and a wide

Pawel Wyszynski ny chef för Investor Relations på SEB29.5.2020 09:00:00 CESTPressemelding

Pressmeddelande Stockholm 29 maj 2020 Pawel Wyszynski har blivit utnämnd till ny chef för Investor Relations på SEB och tillträder sin tjänst den 7 september 2020. Pawel Wyszynski har tidigare varit chef för Shareholder Relations på EQT och har en gedigen bakgrund som aktieanalytiker på Nordea, Danske Bank och Crédit Agricole Cheuvreux. Den nuvarande chefen för Investor Relations, Christoffer Geijer, kommer att tillträda en tjänst inom ledningen för SEB Investment Management, där han kommer att leda arbetet med att optimera distributionen av SEB IM:s produktutbud. För mer information kontakta Frank Hojem, chef Corporate Communication 08-763 9947 frank.hojem@seb.se SEB är en ledande nordisk finansiell koncern. Vi tror starkt på att entreprenöriellt tänkande och innovativa företag behövs för att skapa en bättre värld, och med ett långsiktigt perspektiv stöttar vi våra kunder i både med- och motgång. I Sverige och i de baltiska länderna erbjuder vi ett stort spann av finansiella tjänster